| 2019 | International Journal of Molecular Sciences 9Age-related NAD+ decline | McReynolds et al
Studies indicate improvements in inflammatory markers, though again, distinguishing direct anti-inflammatory effects from those secondary to metabolic improvement remains challenging
Common side effects of BPC-157 arent usually serious and may include: Mild injection site reactions (itching, redness, swelling, pain, etc.) Headaches Dizziness Nausea In rare cases, patients may experience fevers, blistering at the injection site, muscle aches, rashes, vomiting, hives, or other signs of an allergic reaction
It can support metabolic control
The post includes treatment adherence readiness as a screening factor because GLP-1 therapy requires consistent administration over time, and motivation plus reliable access to refills influence how likely it is to work
So he didn't go too fast